Current market catalysts

Morgan Stanley Maintains Overweight on Ionis Pharmaceuticals, Lowers Price Target to $104

Morgan Stanley Initiates Coverage On First Horizon with Equal-Weight Rating, Announces Price Target of $30

Morgan Stanley Upgrades Flagstar Bank to Overweight, Raises Price Target to $17

Morgan Stanley Upgrades East West Bancorp to Overweight, Raises Price Target to $160

Morgan Stanley Downgrades Customers Bancorp to Underweight, Raises Price Target to $89

ABM Isn’t Just Cleaning Buildings Anymore — Its Data Center Pipeline Is Multiplying

ABM stock jumps 7% after beating Q3 2026 earnings estimates, boosted by semiconductor and data center growth. Read the snapshot.

Morgan Stanley Upgrades Cullen/Frost Bankers to Overweight, Raises Price Target to $200

Morgan Stanley Upgrades Commerce Bancshares to Overweight, Raises Price Target to $76

Morgan Stanley Downgrades Central Bancompany to Equal-Weight, Raises Price Target to $36

Morgan Stanley Downgrades Bank OZK to Underweight, Maintains Price Target to $56

Watching Taiwan Semiconductor Manufacturing; Hearing Investor Business Daily SwingTrader Buys Stock

Morgan Stanley Initiates Coverage On PDF Solutions with Overweight Rating, Announces Price Target of $62

Morgan Stanley Upgrades Synopsys to Overweight, Maintains Price Target to $500

8-K filing — Federal Home Loan Bank of Dallas

Filed: 2026-09-08 AccNo: 0001331757-26-000163 Size: 204 KB Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K filing — Healthcare Triangle, Inc. (HCTI)

Filed: 2026-09-08 AccNo: 0001213900-26-097953 Size: 606 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

Morgan Stanley Upgrades M&T Bank to Overweight, Raises Price Target to $304

Why Is Lumentum Stock Surging on Tuesday?

Lumentum Holdings Inc (NASDAQ: LITE) stock gains Tuesday following a major optical fiber supply deal between Corning and Verizon Communications.

Morgan Stanley Downgrades Peloton Interactive to Underweight, Lowers Price Target to $4.5

Does Michael Burry Have It Wrong? Nvidia Chips Retain Value, Data Shows

Nvidia’s 6-year-old A100 chips still carry nearly $5,000 in estimated value, challenging Michael Burry’s AI depreciation warning.

HC Wainwright & Co. Maintains Buy on Roivant Sciences, Raises Price Target to $47

A Rivals Clinical Stumble Sends Sarepta Therapeutics Stock Lower

Sarepta Therapeutics shares react to Novartis Phase 3 trial results in DM1 while Sarepta progresses its SRP-1003 RNA therapy clinical trials.

Piper Sandler Maintains Overweight on Equity Bancshares, Raises Price Target to $60

Why Oracle Stock is the Trade to Watch After OpenAI's AGI Claim

Oracle's $300 billion OpenAI deal makes it an AGI infrastructure proxy. Thursday's earnings will test cloud growth and backlog conversion.

Piper Sandler Reiterates Overweight on Shopify, Raises Price Target to $180

Why Is Cipher Digital Stock Surging on Tuesday?

Cipher Digital Inc (NASDAQ: CIFR) stock is trading higher Tuesday after announcing lateral pipeline developments for high-performance computing data centers.

Stifel Maintains Buy on Hinge Health, Raises Price Target to $115

B. Riley Securities Maintains Neutral on eGain, Lowers Price Target to $6

Novartis Myotonic Dystrophy Trial Flop Sends Dyne Therapeutics Shares Tumbling

Dyne Therapeutics stock sinks on Novartis' failed Phase 3 myotonic dystrophy study, even as Dyne prepares new trial data presentations.

HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target

U.S. Cyber, Law Enforcement Officials Accuse Chinese AI Companies Of 'Aggressive, Industrial-Scale Distillation Activities'